-
effectivehealthcare.ahrq.gov/products/srdrplus
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/insomnia/www.effectivehealthcare.ahrq.gov
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/antipsychotics
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/radiation-therapy-brain-metastases
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/methods-quantitative-synthesis-update
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/methods-guidance-bias/methods/41
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/registries-guide-3rd-edition-addendum
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/registries-guide-update
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products?fB0D=field_product_typeAresearch_report&fB1D=field_product_typeAsystematic_review&fB2D=field_product_typeAtechnical_brief&sort_by=field_product_pub_date
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products?f%B0%5D=field_product_type%3Acme_ce
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/ptsd-repository-expanded
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/health-systems-use-evidence/crt
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/insulin-blood-sugar-2010/sites/default/files
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/insulin-blood-sugar-2010/sites/default
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/products/insulin-blood-sugar-2010/sites
September 23, 2021 - White Paper
March 19, 2021
Antibody Response Following SARS-CoV-2 Infection and Implications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Evidence%20Summary.pdf
October 01, 2021 - Implications and Conclusions
A central dilemma facing interventions intended to reduce the healthcare … sort_by=field_product_pub_date
Main Points
Background and Purpose
Methods
Results
Limitations
Implications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-evidence-summary.pdf
October 01, 2021 - Implications and Conclusions
A central dilemma facing interventions intended to reduce the healthcare … sort_by=field_product_pub_date
Main Points
Background and Purpose
Methods
Results
Limitations
Implications
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
May 01, 2020 - No.20-EHC014-1
May 2020
4
Implications and Conclusions
Compared with treatment as usual ( … sort_by=field_product_pub_date
Main Points
Background and Purpose
Methods
Results
Limitations
Implications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
January 01, 2022 - Implications and Conclusions
This report updates the previous AHRQ report with comprehensive data, calculated … effectivehealthcare.ahrq.gov/products/search
Main Points
Background and Purpose
Methods
Results
Limitations
Implications
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
December 01, 2020 - Implications and Conclusions
High and moderate strength of evidence support the effectiveness of triptans … The lack of risk
assessment tools and mitigation strategies has major implications for practical
implementation … : Opioid Therapy
KQ2: Nonopioid Pharmacologic Therapy
KQ3: Nonpharmacologic Therapy
Limitations
Implications